Author Correction: Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction Notice: Inhibition of TRIP-Br2, a key modulator of lipid breakdown, thermogenic activity, and oxidative processes, mitigates obesity and insulin resistance linked to diet.

  • By

  • Chong Wee Liew

  • Jeremie Boucher

  • Jit Kong Cheong

  • Cecile Vernochet

  • Ho-Jin Koh

  • Cristina Mallol

  • Kristy Townsend

  • Dominique Langin

  • Dan Kawamori

  • Jiang Hu

  • Yu-Hua Tseng

  • Marc K Hellerstein

  • Stephen R Farmer

  • Laurie Goodyear

  • Alessandro Doria

  • Matthias Blüher

  • Stephen I-Hong Hsu

  • Rohit N Kulkarni

  • September 9, 2026

Share

Clinical Scorecard: Correction Notice: Inhibition of TRIP-Br2, a key modulator of lipid breakdown, thermogenic activity, and oxidative processes, mitigates obesity and insulin resistance linked to diet.

At a Glance

CategoryDetail
ConditionClinical topic addressed by the source article: Correction Notice
Key MechanismsMechanisms or clinical associations described in the source article.
Target PopulationPatients or participants described in the source article.
Care SettingSpecify the type of clinical research or metabolic studies.

Key Highlights

  • highlights

Guideline-Based Recommendations

Diagnosis

  • Include relevant diagnostic criteria or guidelines.

Management

  • Include management strategies or recommendations.

Monitoring & Follow-up

  • Include monitoring guidelines if applicable.

Risks

  • Include any associated risks or considerations.

Patient & Prescribing Data

Specify the patient population relevant to the study.

Provide insights on treatment based on the findings.

Clinical Best Practices

  • best_practices

Related Resources & Content

Original Source(s)

Related Content